PostDoc Position:"Development of a new COVID19 therapy in collaboration with a spin-off company and a highly stimulating European Consortium"
Contact Person: Purificación Domínguez
(Centre of Research in Molecular Medicine and Chronic Diseases (CIMUS),
Spain)More information (Publication date:
November 30,
2022)
/ (Deadline: December 30,
2022)
PostDoc Position:"Theranostics of Glioblastoma using Nanotechnology"
(Centre of Research in Molecular Medicine and Chronic Diseases (CIMUS),
Spain)
(Publication date:
November 30,
2022)
/ (Deadline:CLOSED)
Job Position:"Technical assistant contract offer"
Contact Person: Purificación Domínguez
(Centre of Research in Molecular Medicine and Chronic Diseases (CIMUS),
Spain)More information (Publication date:
November 30,
2022)
/ (Deadline: December 30,
2022)
Job Position:"Research Engineer – Electron Microscopy and Spectroscopy"
Contact Person: Enrique Carbo
(INL,
Portugal)More information (Publication date:
November 29,
2022)
/ (Deadline: January 10,
2023)
Job Position:"Research Engineer – Electron Microscopy and Spectroscopy"
Contact Person: Enrique Carbo
(INL,
Portugal)More information (Publication date:
November 29,
2022)
/ (Deadline: January 10,
2023)
PostDoc Position:"Nanostructured Functional Materials group (MIASKIN PROJECT)"
(ICN2,
Spain)
(Publication date:
November 14,
2022)
/ (Deadline:CLOSED)
PostDoc Position:"Nanostructured Functional Materials group (COVICAP PROJECT)"
(ICN2,
Spain)
(Publication date:
November 14,
2022)
/ (Deadline:CLOSED)
Job Position:"Research Support Technician - Nanostructured Functional Materials group (BIASKIN PROJECT)"
(ICN2,
Spain)
(Publication date:
November 14,
2022)
/ (Deadline:CLOSED)
Job Position:"Research Support Technician - Nanostructured Functional Materials group (SOLAR)"
(ICN2,
Spain)
(Publication date:
November 14,
2022)
/ (Deadline:CLOSED)
Job Position:"Research Support Technician - Nanostructured Functional Materials group (TRANSWIN)"
(ICN2,
Spain)
(Publication date:
November 14,
2022)
/ (Deadline:CLOSED)
PostDoc Position:"Development of a new COVID19 therapy in collaboration with a spin-off company and a highly stimulating European Consortium" 